These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15359855)

  • 1. [Prevention of adverse effects in ribavirin and interferon combination therapy].
    Izumi N
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):523-7. PubMed ID: 15359855
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple fixed drug eruption with interferon/ribavirin combination therapy for hepatitis C virus infection.
    Sidhu-Malik NK; Kaplan AL
    J Drugs Dermatol; 2003 Oct; 2(5):570-3. PubMed ID: 14558408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of hepatitis C: therapeutic management].
    Bourliere M
    Gastroenterol Clin Biol; 2008 May; 32(5 Pt 2):S166-71. PubMed ID: 18482813
    [No Abstract]   [Full Text] [Related]  

  • 4. Predictors of hematological abnormalities in patients with chronic hepatitis C treated with interferon and ribavirin.
    Nachnani JS; Rao GA; Bulchandani D; Pandya PK; Alba LM
    Ann Hematol; 2010 Feb; 89(2):121-5. PubMed ID: 19565241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The adherence in the treatment of chronic hepatitis C].
    Pawłowska M; Halota W
    Pol Merkur Lekarski; 2005 Apr; 18(106):469-72. PubMed ID: 16161937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orally administered Kampo medicine, Juzen-taiho-to, ameliorates anemia during interferon plus ribavirin therapy in patients with chronic hepatitis C.
    Sho Y; Fujisaki K; Sakashita H; Yamaguchi K; Tahara K; Kubozono O; Ido A; Tsubouchi H
    J Gastroenterol; 2004 Dec; 39(12):1202-4. PubMed ID: 15622486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etanercept as prophylactic psoriatic therapy before interferon-alpha and ribavirin treatment for active hepatitis C infection.
    Behnam SE; Hindiyeh R; Fife DJ; Jeffes EW; Wu JJ
    Clin Exp Dermatol; 2010 Jun; 35(4):397-8. PubMed ID: 19663835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffuse cutaneous eruption due to interferon alfa and ribavirin treatment of chronic hepatitis C.
    Savk E; Uslu G; Karaoğlu AO; Sendur N; Karaman G
    J Eur Acad Dermatol Venereol; 2005 May; 19(3):396-8. PubMed ID: 15857485
    [No Abstract]   [Full Text] [Related]  

  • 9. [Side effects of interferon therapy for chronic hepatitis C].
    Arase Y
    Nihon Rinsho; 2006 Jul; 64(7):1363-7. PubMed ID: 16838657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irritability: an underappreciated side effect of interferon treatment for chronic hepatitis C?
    Blacklaws H; Gardner A; Usher K
    J Clin Nurs; 2011 May; 20(9-10):1215-24. PubMed ID: 21371144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current treatment for chronic hepatitis C.
    Davis GL
    Rev Gastroenterol Disord; 2001; 1(2):59-72. PubMed ID: 12120176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating treatment of hepatitis C for hemolytic anemia management.
    DebRoy S; Kribs-Zaleta C; Mubayi A; Cardona-Meléndez GM; Medina-Rios L; Kang M; Diaz E
    Math Biosci; 2010 Jun; 225(2):141-55. PubMed ID: 20303990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paternal exposure to ribavirin: pregnancy and neonatal outcome.
    De Santis M; Carducci B; Cavaliere AF; De Santis L; Lucchese A; Straface G; Caruso A
    Antivir Ther; 2003 Feb; 8(1):73-5. PubMed ID: 12713067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon induced glomerular disease in a patient with chronic hepatitis C.
    Suresh RL; Suryati Y; Merican I
    Med J Malaysia; 2003 Oct; 58(4):594-6. PubMed ID: 15190636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An adult case with onset of celiac disease during chronic hepatitis C antiviral treatment.
    Ioniţă-Radu F; Bucurică S; Costache R; Nuţă P; Stanciu S
    Rom J Intern Med; 2010; 48(1):105-8. PubMed ID: 21180248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ifn/Rbv treatment induced anemia and its correction with epoetin alpha in patients with hepatitis C.
    Sharvadze L; Tsertsvadze T; Gochitashvili N; Kakabadze T; Dolmazashvili E
    Georgian Med News; 2006 Aug; (137):62-5. PubMed ID: 16980747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anemia--a complication of antiviral treatment in chronic viral hepatitis C.
    Orāşan O; Cozma A; Rednic N; Sâmpelean D; Pârvu A; Petrov L
    Rom J Intern Med; 2009; 47(3):217-25. PubMed ID: 20446436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematologic adverse effects and efficacy monitoring in chronic Hepatitis C patients treated with interferon and ribavirin combination therapy.
    Rafique G; Bukhsh A; Gul A; Khiljee S; Ashraf M; Omer MO
    Pak J Pharm Sci; 2017 Jan; 30(1):11-16. PubMed ID: 28603106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of chronic hepatitis C in sickle cell disease and thalassaemic patients with interferon and ribavirin.
    Ancel D; Amiot X; Chaslin-Ferbus D; Hagege I; Garioud A; Girot R; Pol S; Grange JD
    Eur J Gastroenterol Hepatol; 2009 Jul; 21(7):726-9. PubMed ID: 19404206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anemia during treatment of hepatitis C in HIV-infected patients.
    Lo Re V; Kostman JR
    AIDS Read; 2004 Oct; 14(10):555-7, 562, 565-71. PubMed ID: 15510392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.